SPY420.86+5.94 1.43%
DIA338.78+5.82 1.75%
IXIC14,141.48+111.10 0.79%

Design Therapeutics Q1 EPS $(0.31) Down From $(0.04) YoY

Design Therapeutics (NASDAQ:DSGN) reported quarterly losses of $(0.31) per share. This is a 675 percent decrease over losses of $(0.04) per share from the same period last year.

05/10/2021 16:27
Design Therapeutics (NASDAQ:DSGN) reported quarterly losses of $(0.31) per share. This is a 675 percent decrease over losses of $(0.04) per share from the same period last year.